1. Home
  2. TIL vs SPCE Comparison

TIL vs SPCE Comparison

Compare TIL & SPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TIL
  • SPCE
  • Stock Information
  • Founded
  • TIL 2018
  • SPCE 2017
  • Country
  • TIL United States
  • SPCE United States
  • Employees
  • TIL N/A
  • SPCE N/A
  • Industry
  • TIL Biotechnology: Pharmaceutical Preparations
  • SPCE Transportation Services
  • Sector
  • TIL Health Care
  • SPCE Consumer Discretionary
  • Exchange
  • TIL Nasdaq
  • SPCE Nasdaq
  • Market Cap
  • TIL 177.1M
  • SPCE 181.4M
  • IPO Year
  • TIL 2021
  • SPCE N/A
  • Fundamental
  • Price
  • TIL $31.50
  • SPCE $3.23
  • Analyst Decision
  • TIL Buy
  • SPCE Hold
  • Analyst Count
  • TIL 6
  • SPCE 6
  • Target Price
  • TIL $120.50
  • SPCE $9.54
  • AVG Volume (30 Days)
  • TIL 109.0K
  • SPCE 2.5M
  • Earning Date
  • TIL 08-13-2025
  • SPCE 11-05-2025
  • Dividend Yield
  • TIL N/A
  • SPCE N/A
  • EPS Growth
  • TIL N/A
  • SPCE N/A
  • EPS
  • TIL N/A
  • SPCE N/A
  • Revenue
  • TIL N/A
  • SPCE $1,698,000.00
  • Revenue This Year
  • TIL N/A
  • SPCE N/A
  • Revenue Next Year
  • TIL N/A
  • SPCE $2,869.26
  • P/E Ratio
  • TIL N/A
  • SPCE N/A
  • Revenue Growth
  • TIL N/A
  • SPCE N/A
  • 52 Week Low
  • TIL $10.80
  • SPCE $2.18
  • 52 Week High
  • TIL $92.00
  • SPCE $8.19
  • Technical
  • Relative Strength Index (RSI)
  • TIL 61.57
  • SPCE 50.74
  • Support Level
  • TIL $26.69
  • SPCE $3.04
  • Resistance Level
  • TIL $28.85
  • SPCE $3.15
  • Average True Range (ATR)
  • TIL 2.16
  • SPCE 0.13
  • MACD
  • TIL 0.43
  • SPCE 0.02
  • Stochastic Oscillator
  • TIL 76.70
  • SPCE 55.36

About TIL Instil Bio Inc.

Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.

About SPCE Virgin Galactic Holdings Inc.

Virgin Galactic Holdings Inc is a United States-based vertically integrated aerospace company pioneering human spaceflight for private individuals & researchers, and it also manufactures air and space vehicles. Using technologies, the company is developing a spaceflight system designed to offer its customers a multi-day, and transformative experience. This culminates in a spaceflight that includes views of Earth from space and several minutes of weightlessness that will launch from Spaceport America, New Mexico.

Share on Social Networks: